Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Chronic oligodendrogenesis and remyelination after spinal cord injury in mice and rats.
A case of multiple sclerosis with pure, massive superficial demyelination.
Multiple Sclerosis Increases Fracture Risk: A Meta-Analysis.
New TYSABRI® analysis at AAN annual meeting shows improved walking speed in significant number of MS patients
CNS response to a second pro-inflammatory event depends on whether the primary demyelinating lesion is active or resolved.
Proteomic analysis of the cerebrospinal fluid in multiple sclerosis and neuromyelitis optica patients.
The cuprizone model: regional heterogeneity of pathology.
Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia.
Induction of pluripotent stem cells from adult human fibroblasts by defined factors.
Comparison of Standard 1.5 T vs. 3 T Optimized Protocols in Patients Treated with Glatiramer Acetate. A Serial MRI Pilot Study.
Bispecificity for Myelin and Neuronal Self-Antigens Is a Common Feature of CD4 T Cells in C57BL/6 Mice.
Maraviroc and JC virus-associated immune reconstitution inflammatory syndrome.
Arterial, venous and other vascular risk factors in multiple sclerosis.
Pathogenic CD8 T cells in multiple sclerosis and its experimental models.
UDP-glucose enhances outward K(+) currents necessary for cell differentiation and stimulates cell migration by activating the GPR17 receptor in oligodendrocyte precursors.
Polymorphism of Apo lipoprotein E gene and the risk of multiple sclerosis.
Fingolimod targeting protein phosphatase 2A differently affects IL-33 induced IL-2 and IFN-γ production in CD8(+) lymphocytes.
Changes in nociceptive sensitivity and object recognition in experimental autoimmune encephalomyelitis (EAE).
Oligoclonal bands predict multiple sclerosis in children with optic neuritis.
Deliberate Fingolimod Overdose Presenting with Delayed Hypotension and Bradycardia Responsive to Atropine.
Modulation of alertness by sustained cognitive demand in MS as surrogate measure of fatigue and fatigability.
Cell therapy for multiple sclerosis: an evolving concept with implications for other neurodegenerative diseases.
K(+) channel alterations in the progression of experimental autoimmune encephalomyelitis.
Delta-9-tetrahydrocannabinol + cannabidiol. A reasonable option for some patients with multiple sclerosis.
Development of a high-resolution fat and CSFsuppressed optic nerve DTI protocol at 3T: application in multiple sclerosis.

Pages